| Literature DB >> 31496822 |
Sunday Oluwafemi Oyeyemi1, Tonje Braaten1, Edoardo Botteri2,3, Paula Berstad2, Kristin Benjaminsen Borch1.
Abstract
PURPOSE: Norway has experienced an unexplained, steep increase in colorectal cancer (CRC) incidence in the last half-century, with large differences across its counties. We aimed to determine whether geographical distribution of lifestyle-related CRC risk factors can explain these geographical differences in CRC incidence in Norwegian women.Entities:
Keywords: NOWAC study; colorectal cancer; diet; lifestyle; risk factors; women
Year: 2019 PMID: 31496822 PMCID: PMC6691490 DOI: 10.2147/CLEP.S207413
Source DB: PubMed Journal: Clin Epidemiol ISSN: 1179-1349 Impact factor: 4.790
Figure 1Map of Norway showing the 19 counties and regions.
Basic parameters and endpoints in the 19 counties of Norway in the Norwegian Women and Cancer Study
| Counties | Sample population per county | Number of CRC cases | Incidence proportion of CRC (%) | Crude incidence rate per 100,000 | Average follow-up time in years | Person-years at risk |
|---|---|---|---|---|---|---|
| Østfold | 4836 | 106 | 2.2 | 146 | 15.0 | 72,563 |
| Akershus | 9661 | 177 | 1.8 | 121 | 15.1 | 146,259 |
| Oslo | 8439 | 142 | 1.7 | 111 | 15.1 | 127,573 |
| Hedmark | 3808 | 62 | 1.6 | 108 | 15.2 | 57,671 |
| Opplanda | 3544 | 47 | 1.3 | 88 | 15.0 | 53,315 |
| Buskerud | 4496 | 78 | 1.7 | 115 | 15.1 | 67,970 |
| Vestfold | 4267 | 81 | 1.9 | 125 | 15.2 | 64,808 |
| Telemark | 3137 | 45 | 1.4 | 96 | 15.0 | 46,975 |
| Aust-Agder | 1827 | 34 | 1.9 | 123 | 15.1 | 27,640 |
| Vest-Agder | 2715 | 47 | 1.7 | 114 | 15.1 | 41,088 |
| Rogaland | 6503 | 117 | 1.8 | 119 | 15.2 | 98,500 |
| Hordaland | 7736 | 130 | 1.7 | 110 | 15.2 | 117,863 |
| Sogn og Fjordaneb | 1889 | 49 | 2.6 | 171 | 15.2 | 28,655 |
| Møre og Romsdal | 4653 | 80 | 1.7 | 112 | 15.3 | 71,354 |
| Sør Trøndelag | 4882 | 67 | 1.4 | 91 | 15.1 | 73,835 |
| Nord-Trøndelag | 2607 | 45 | 1.7 | 114 | 15.2 | 39,530 |
| Nordland | 11,443 | 322 | 2.8 | 169 | 16.7 | 190,621 |
| Troms | 7264 | 176 | 2.4 | 146 | 16.6 | 120,723 |
| Finnmark | 3186 | 70 | 2.2 | 132 | 16.7 | 53,171 |
| Total | 96,893 | 1,875 | 1.9 | 125 | 15.5 | 1,500,112 |
Notes: aCounty with lowest CRC incidence. bCounty with highest CRC incidence.
Abbreviation: CRC, colorectal cancer.
Selected participant characteristics by county group at study enrollment (baseline) in the Norwegian Women and Cancer Study
| Characteristics | Low incidence: (Oppland, Sør-Trøndelag, Telemark) | Mid-low incidence: (Hedmark, Hordaland, Oslo, Møre and Romsdal, Nord-Trøndelag, Vest-Agder, Buskerud) | Mid-high incidence: (Rogaland, Akershus, Aust-Agder, Vestfold, Østfold, Troms, Finnmark) | High incidence: (Nordland, Sogn and Fjordane) |
|---|---|---|---|---|
| Population | 11,563 | 34,454 | 37,544 | 13,332 |
| Colorectal cancer, n (% in the area) | 159 (1.4) | 584 (1.7) | 761 (2.0) | 371 (2.8) |
| Crude incidence rate per 100,000 | 91 | 112 | 130 | 169 |
| Mean age at baseline in years | 51.6 | 51.6 | 52.1 | 53.7 |
| Physical activity (% active, 6–10) | 46 | 46 | 44 | 41 |
| Mean height in cm (SE) | 166 (0.05) | 167 (0.03) | 166 (0.03) | 165 (0.05) |
| Mean body mass index (SE) | 24.9 (0.04) | 24.6 (0.02) | 24.8 (0.02) | 25.1 (0.03) |
| Mean duration of education in years (SE) | 12.2 (0.03) | 12.5 (0.02) | 12.0 (0.02) | 10.9 (0.03) |
| Mean alcohol intake in g/day (SE) | 3.5 (0.04) | 3.9 (0.03) | 3.6 (0.02) | 2.6 (0.03) |
| Smoking history, % | ||||
Never | 38 | 38 | 37 | 34 |
Former | 31 | 32 | 32 | 32 |
Current | 29 | 28 | 30 | 32 |
(% of ever smokers) | (60) | (60) | (62) | (64) |
| Annual household income, % | ||||
Low (<300,000 NOK) | 36 | 33 | 35 | 48 |
Medium (300,000–600,000 NOK) | 45 | 45 | 443.6 | 38 |
High (>600,000 NOK) | 12 | 15 | 14 | 5 |
| Hormone therapy use (% of ever users) | 34 | 35 | 33 | 30 |
| Oral contraceptive use (% of ever users) | 53 | 55 | 52 | 43 |
| Dietary factors | ||||
| Mean red meat intake in g/day (SE) | 14.3 (0.10) | 14.8 (0.06) | 15.4 (0.06) | 15.0 (0.10) |
| Mean processed meat in g/day (SE) | 68.9 (0.38) | 69.1 (0.23) | 68.6 (0.21) | 60.8 (0.33) |
| Mean fish intake in g/day (SE) | 87.2 (0.50) | 92.4 (0.30) | 96.9 (0.31) | 121.0 (0.60) |
| Fruit and vegetables intake in g/day (SE) | 337 (1.9) | 349 (1.1) | 333 (1.0) | 292 (1.6) |
| Mean fiber intake in g/day (SE) | 21.2 (0.08) | 21.5 (0.04) | 20.9 (0.04) | 20.6 (0.06) |
| Calcium intake in mg/day (SE) | 745 (3.4) | 740 (1.6) | 744 (1.7) | 730 (2.7) |
| Vitamin D in μg/day (SE) | 8.56 (0.08) | 8.65 (0.04) | 9.10 (0.04) | 9.36 (0.07) |
Abbreviation: SE, standard error.
Comparison of the complete-case and imputed dataset, the Norwegian Women and Cancer study
| Characteristics | Missing n (%) | Complete-case mean (SD), or % | Multiply imputed mean (SD), or % | |
|---|---|---|---|---|
| County of residence | 0 (0) | |||
| Low incidence (%) | 12 | 12 | ||
| Mid-low incidence (%) | 36 | 36 | ||
| Mid-high incidence (%) | 39 | 39 | ||
| High incidence (%) | 14 | 14 | ||
| Age at baseline (SD) | 0 (0) | 52.1 (6.7) | 52.1 (6.7) | |
| Physical activity (SD) | 9,214 (9.5) | 5.6 (1.8) | 5.5 (1.8) | |
| Height (SD) | 561 (0.6) | 166.1 (5.7) | 166.1 (5.7) | |
| Body mass index (SD) | 2,187 (2.3) | 24.8 (4.0) | 24.8 (4.0) | |
| Duration of education (SD) | 5,601 (5.8) | 12.1 (3.5) | 12.0 (3.5) | |
| Alcohol intake (SD) | 1,958 (2.0) | 3.6 (4.5) | 3.5 (4.5) | |
| Smoking status (%) | 1,869 (1.9) | |||
| Never (%) | 37 | 37 | ||
| Ex (%) | 33 | 33 | ||
| Current (%) | 30 | 30 | ||
| Pack years (SD) | 6 (0.01) | 6.3 (8.5) | 6.3 (8.5) | |
| Annual household income | 7,054 (7.3) | |||
| Low (%) | 39 | 39 | ||
| Medium (%) | 47 | 47 | ||
| High (%) | 14 | 14 | ||
| Hormone replacement therapy use | 2,793 (2.9) | |||
| Never (%) | 66 | 66 | ||
| Ever (%) | 34 | 34 | ||
| Oral contraceptive use | 3,695 (3.8) | |||
| Never (%) | 54 | 53 | ||
| Ever (%) | 46 | 47 |
Abbreviation: SD, standard deviation.
Figure 2Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) of factors associated with colorectal cancer (CRC) incidence at baseline and follow-up with chained multiple imputations, in the Norwegian Women and Cancer study.
Hazard ratios (HRs) and 95% confidence intervals (CIs) before and after multivariable risk adjustment at baseline (complete-case analysis) in the Norwegian Women and Cancer study
| Groupings by | Baseline (complete-case analysis) | Baseline and follow-up (with chained multiple imputation) | |||
|---|---|---|---|---|---|
| Crude (unadjusted)a | Multivariable adjustedb | Crude (unadjusted)a | Multivariable adjustedb | ||
| Categories | HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | |
| CRC incidence | Low | 1.00 | 1.00 | 1.00 | 1.00 |
| Mid-low | 1.29 (1.04–1.59) | 1.29 (1.05–1.59) | 1.22 (1.03–1.46) | 1.25 (1.05–1.49) | |
| Mid-high | 1.37 (1.12–1.69) | 1.39 (1.13–1.71) | 1.30 (1.10–1.55) | 1.32 (1.11–1.56) | |
| High | 1.51 (1.20–1.89) | 1.52 (1.20–1.92) | 1.41 (1.17–1.71) | 1.37 (1.13–1.66) | |
| Regions | Oslo | 1.00 | 1.00 | 1.00 | 1.00 |
| East | 1.03 (0.84–1.26) | 1.05 (1.85–1.29) | 1.06 (0.88–1.27) | 1.03 (0.86–1.24) | |
| South | 1.08 (0.79–1.48) | 1.10 (0.80–1.51) | 1.08 (0.82–1.41) | 1.04 (0.79–1.37) | |
| West | 1.12 (0.90–1.40) | 1.18 (0.94–1.48) | 1.08 (0.89–1.31) | 1.07 (0.88–1.30) | |
| Middle | 0.83 (0.62–1.11) | 0.85 (0.64–1.14) | 0.91 (0.71–1.16) | 0.87 (0.68–1.12) | |
| North | 1.04 (0.84–1.28) | 1.05 (0.84–1.32) | 1.03 (0.85–1.24) | 0.95 (0.78–1.16) | |
| Rural–urban area of residence | Rural | 1.00 | 1.00 | 1.00 | 1.00 |
| Rrban | 1.04 (0.94–1.16) | 1.05 (0.94–1.17) | 1.03 (0.94–1.12) | 1.05 (0.96–1.15) | |
Notes: aUnadjusted except for age (age was used as the time scale). bAdjusted for age, physical activity, height, body mass index, duration of education, alcohol intake, smoking history, hormone replacement therapy use, oral contraceptive use, annual household income, and dietary factors.
Decomposition of total effects of county groups into direct and indirect effects using the Karlson, Holm, and Breen method at baseline and follow-up in the Norwegian Women and Cancer Study
| County groups | Baseline data | Imputed data | |||
|---|---|---|---|---|---|
| Coefficient (95% CI) | Coefficient (95% CI) | ||||
| Low incidence | (base outcome) | – | – | – | – |
| Mid-low incidence | |||||
| Reduced model | 0.252 (0.040, 0.463) | 0.020 | 0.198 (0.021, 0.375) | 0.028 | |
| Full model | 0.253 (0.041, 0.465) | 0.019 | 0.205 (0.028, 0.383) | 0.023 | |
| Difference | −0.001 (−0.018, 0.016) | 0.880 | −0.007 (−0.022, 0.007) | 0.316 | |
| Mid-high incidence | |||||
| Reduced model | 0.317 (0.109, 0.526) | 0.003 | 0.268 (0.095, 0.442) | 0.002 | |
| Full model | 0.321 (0.113, 0.530) | 0.003 | 0.277 (0.103, 0.451) | 0.002 | |
| Difference | −0.004 (−0.024, 0.016) | 0.690 | −0.009 (−0.026, 0.008) | 0.228 | |
| High incidence | |||||
| Reduced model | 0.409 (0.175, 0.642) | 0.001 | 0.342 (0.150, 0.535) | <0.001 | |
| Full model | 0.388 (0.152, 0.624) | 0.001 | 0.323 (0.129, 0.518) | 0.001 | |
| Difference | 0.021 (−0.016, 0.057) | 0.263 | 0.019 (−0.013, 0.048) | 0.253 |
Abbreviation: CI, confidence interval.